OptiNose Inc. (NASDAQ: OPTN) is -53.90% lower on its value in year-to-date trading and has touched a low of $3.28 and a high of $11.66 in the current 52-week trading range. The OPTN stock was last observed hovering at around $4.25 in the recent trading session, with the current gains setting it 0.12% off its average median price target of $18.50 for the next 12 months. It is also 78.15% off the consensus price target high of $20.00 offered by 6 analysts, but current levels are 66.38% higher than the price target low of $13.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
At last check, trading at $4.37, the stock is -27.80% and -14.55% below its SMA20 and SMA50 respectively. However, with a current trading volume of 0.61 million and changing 2.82% at the moment leaves the stock -34.87% off its SMA200. OPTN registered -42.88% loss for a year compared to 6-month loss of -45.65%. The firm has a 50-day simple moving average (SMA 50) of $5.5687 and a 200-day simple moving average (SMA200) of $5.8928.
The stock witnessed a -22.30% gain in the last 1 month and extending the period to 3 months gives it a 7.05%, and is -42.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.17% over the week and 12.77% over the month.
OptiNose Inc. (OPTN) has around 102 employees, a market worth around $214.63M and $37.20M in sales. Distance from 52-week low is 33.23% and -62.52% from its 52-week high. The company has generated returns on investments over the last 12 months (-75.50%).
OptiNose Inc. (OPTN) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for OptiNose Inc. (OPTN) is a “Buy”. 6 analysts offering their recommendations for the stock have an average rating of 1.80, where 0 rate it as a Hold and 0 think it is a “Overweight”. 6 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
OptiNose Inc. is expected to release its quarterly report on 08/12/2020 and quarterly earnings per share for the current quarter are estimated at -$0.56 with sales reaching $9.74M over the same period.The EPS is expected to grow by 2.00% this year, but quarterly earnings will post 50.10% year-over-year. Quarterly sales are estimated to grow 48.50% in year-over-year returns.
OptiNose Inc. (OPTN) Top Institutional Holders
143 institutions hold shares in OptiNose Inc. (OPTN), with 6.48M shares held by insiders accounting for 14.12% while institutional investors hold 125.53% of the company’s shares. The shares outstanding are 45.91M, and float is at 25.01M with Short Float at 23.32%. Institutions hold 107.80% of the Float.
The top institutional shareholder in the company is FMR, LLC with over 6.89 million shares valued at $30.92 million. The investor’s holdings represent 15.00% of the OPTN Shares outstanding. As of Mar 30, 2020, the second largest holder is JP Morgan Chase & Company with 2.94 million shares valued at $13.21 million to account for 6.41% of the shares outstanding. The other top investors are Blackrock Inc. which holds 2.22 million shares representing 4.83% and valued at over $9.96 million, while Boston Private Wealth LLC holds 4.30% of the shares totaling 1.97 million with a market value of $8.87 million.
OptiNose Inc. (OPTN) Insider Activity
A total of 6 insider transactions have happened at OptiNose Inc. (OPTN) in the last six months, with sales accounting for 0 and purchases happening 6 times. The most recent transaction is an insider purchase by O’Neil Robert P, the company’s Director. SEC filings show that O’Neil Robert P bought 5,000 shares of the company’s common stock on Mar 09 at a price of $5.32 per share for a total of $26596.0. Following the purchase, the insider now owns 7000.0 shares.
OptiNose Inc. disclosed in a document filed with the SEC on Mar 06 that Scodari Joseph C (Director) bought a total of 8,700 shares of the company’s common stock. The trade occurred on Mar 06 and was made at $5.70 per share for $49605.0. Following the transaction, the insider now directly holds 21230.0 shares of the OPTN stock.
Still, SEC filings show that on Dec 06, Scodari Joseph C (Director) acquired 6,100 shares at an average price of $8.22 for $50142.0. The insider now directly holds 12,530 shares of OptiNose Inc. (OPTN).
OptiNose Inc. (OPTN): Who are the competitors?
The company’s main competitors (and peers) include OptiNose Inc. (OPTN) that is trading -42.88% down over the past 12 months. Short interest in the company’s stock has fallen -4.46% from the last report on May 14, 2020 to stand at a total of 6.09 million short shares sold with a short interest ratio of 22.99.